Saizen® Solution for Injection Adult Growth Hormone Deficiency (GHD) Immunogenicity Study

NCT01237340 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
59
Enrollment
INDUSTRY
Sponsor class

Stopped The Sponsor voluntarily terminated this trial because compliance to strict Good Clinical Practice (GCP) requirements was not ensured - No safety concerns

Conditions

Interventions

Sponsor

EMD Serono